MAM
Harvest Gold unveils new logo in brand revamp
Mumbai: Harvest Gold, a bakery food brand, has revamped its visual identity with a new logo and packaging to strengthen its brand positioning.
With this fresh transformation, Harvest Gold aims to influence the buying decisions of young Indians, and reinforce the brand ethos ‘Wahi Swaad, Naya Andaaz’, the brand said in a statement on Thursday.
The new packaging brings several changes in the front panel of the packets, including a personalized call-out in every variant, a wider red strip, use of new-age font, better visibility of product type, and use of logo beyond the seal of the packet, it added.
Speaking about the brand makeover, Harvest Gold’s MD Raj Kanwar Singh shared, “The new logo of Harvest Gold is quintessentially Indian. It has been designed keeping in mind the fact that our audience is becoming more diverse every day. The new logo resonates with the vibrant and dynamic spirit of young and effervescent India. The sun in the new Logo reflects the energy and rededicated hope that inspires people to make the best of each day.”
The new design will be visible on all Harvest Gold products, as well as in shops, on vehicles, and merchandise starting 9 July.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
